107 related articles for article (PubMed ID: 18588859)
1. TGF-beta activates ERK5 in human renal epithelial cells.
Browne JA; Pearson AL; Zahr RA; Niculescu-Duvaz I; Baines DL; Dockrell ME
Biochem Biophys Res Commun; 2008 Aug; 373(3):440-4. PubMed ID: 18588859
[TBL] [Abstract][Full Text] [Related]
2. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway.
Lee KS; Park JH; Lim HJ; Park HY
Cell Signal; 2011 Jul; 23(7):1100-9. PubMed ID: 21244855
[TBL] [Abstract][Full Text] [Related]
3. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects.
Dwivedi Y; Rizavi HS; Teppen T; Sasaki N; Chen H; Zhang H; Roberts RC; Conley RR; Pandey GN
Neuropsychopharmacology; 2007 Nov; 32(11):2338-50. PubMed ID: 17342168
[TBL] [Abstract][Full Text] [Related]
4. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
[TBL] [Abstract][Full Text] [Related]
5. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
6. Activity assays for extracellular signal-regulated kinase 5.
Nakamura K; Johnson GL
Methods Mol Biol; 2010; 661():91-106. PubMed ID: 20811978
[TBL] [Abstract][Full Text] [Related]
7. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
Suzuki H; Uchida K; Nitta K; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
[TBL] [Abstract][Full Text] [Related]
8. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
Kato Y; Kravchenko VV; Tapping RI; Han J; Ulevitch RJ; Lee JD
EMBO J; 1997 Dec; 16(23):7054-66. PubMed ID: 9384584
[TBL] [Abstract][Full Text] [Related]
9. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW
Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274
[TBL] [Abstract][Full Text] [Related]
10. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
[TBL] [Abstract][Full Text] [Related]
11. A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway.
Seyfried J; Wang X; Kharebava G; Tournier C
Mol Cell Biol; 2005 Nov; 25(22):9820-8. PubMed ID: 16260599
[TBL] [Abstract][Full Text] [Related]
12. DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5.
Arkell RS; Dickinson RJ; Squires M; Hayat S; Keyse SM; Cook SJ
Cell Signal; 2008 May; 20(5):836-43. PubMed ID: 18280112
[TBL] [Abstract][Full Text] [Related]
13. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.
Tatake RJ; O'Neill MM; Kennedy CA; Wayne AL; Jakes S; Wu D; Kugler SZ; Kashem MA; Kaplita P; Snow RJ
Biochem Biophys Res Commun; 2008 Dec; 377(1):120-5. PubMed ID: 18834865
[TBL] [Abstract][Full Text] [Related]
14. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
15. ERK5 promotes Src-induced podosome formation by limiting Rho activation.
Schramp M; Ying O; Kim TY; Martin GS
J Cell Biol; 2008 Jun; 181(7):1195-210. PubMed ID: 18573916
[TBL] [Abstract][Full Text] [Related]
16. Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells.
Zhao Z; Geng J; Ge Z; Wang W; Zhang Y; Kang W
Mol Cell Biochem; 2009 Feb; 322(1-2):171-8. PubMed ID: 19011954
[TBL] [Abstract][Full Text] [Related]
17. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
Barros JC; Marshall CJ
J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
[TBL] [Abstract][Full Text] [Related]
18. Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function.
Feldman G; Kiely B; Martin N; Ryan G; McMorrow T; Ryan MP
J Am Soc Nephrol; 2007 Jun; 18(6):1662-71. PubMed ID: 17460148
[TBL] [Abstract][Full Text] [Related]
19. The ERK5-MEF2C transcription factor pathway contributes to anti-apoptotic effect of cerebral ischemia preconditioning in the hippocampal CA1 region of rats.
Wang RM; Zhang QG; Li J; Yang LC; Yang F; Brann DW
Brain Res; 2009 Feb; 1255():32-41. PubMed ID: 19103177
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor up-regulates transforming growth factor-beta receptor type II in human dermal fibroblasts via p38 mitogen-activated protein kinase pathway.
Yamane K; Asano Y; Tamaki K; Ihn H
Biochem Biophys Res Commun; 2007 Jan; 352(1):69-77. PubMed ID: 17107667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
